Parkinson's disease: experimental models and reality

Area of Science:

• Neuroscience
• Pathology
• Genetics

Background:

• Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by dopaminergic neuron loss and alpha-synuclein (αS) pathology.
• Current rodent models often fail to fully recapitulate the complex clinical and pathological features of PD, hindering research.
• Understanding fundamental cellular processes is crucial for developing more accurate PD models.

Purpose of the Study:

• To review progress in generating rodent models of PD by targeting key cellular dysfunction pathways.
• To evaluate the contribution of impaired mitochondrial oxidative phosphorylation, autophagy-lysosomal metabolism, ubiquitin-proteasome system, and ER stress to PD pathogenesis.
• To discuss the role of αS aggregation, nuclear membrane integrity, and phagocytic clearance in PD model development.

Main Methods:

• Review of existing literature on rodent models of PD.
• Analysis of studies focusing on impairments in major cellular functions: mitochondrial, lysosomal, proteasomal, and ER stress pathways.
• Examination of cell biological studies linking αS aggregation to nuclear membrane integrity and phagocytic clearance.

Main Results:

• Progress has been made in creating PD rodent models by targeting specific cellular impairments.
• Impairments in mitochondrial, lysosomal, proteasomal, and ER stress pathways are implicated in PD pathogenesis.
• αS aggregation, nuclear membrane dysfunction, and impaired phagocytosis are relevant factors for consideration in model development.

Conclusions:

• Targeting major cellular functions offers a promising strategy for developing improved rodent models of Parkinson's disease.
• Further research into these cellular pathways and their interplay with αS pathology is essential for advancing PD understanding and therapeutics.
• Considering factors like nuclear membrane integrity and phagocytic clearance may lead to more comprehensive PD models.